This stock is no longer traded. It was delisted on July 8, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
Vaxxinity Inc. is a biotechnology company focusing on developing next-generation vaccines for chronic and infectious diseases. The primary aim of the company is to democratize health by creating vaccines that are accessible, effective, and grounded in innovative science. Vaxxinity's proprietary platform leverages synthetic peptides to train the immune system, an approach that holds promise for both preventive and therapeutic applications. The company's research and development efforts target key health challenges such as Alzheimer’s disease, Parkinson’s, and hypercholesterolemia, among others. Operating at the forefront of the biotechnology sector, Vaxxinity Inc. plays a significant role in advancing medical science and public health. By addressing unmet clinical needs through its unique vaccine platform, Vaxxinity is contributing to the broad landscape of healthcare solutions, impacting both individual health outcomes and public health policies. The company's innovations are part of a broader trend in the biotechnology industry, where cutting-edge research is rapidly transforming potential therapies into tangible health benefits for populations worldwide.
Website505 Odyssey Way
Merritt Island, FL, 32953
United States
Summary of Sep 1's posts. Generated by AI.
Summary of May 3's posts. Generated by AI.
Summary of May 3's posts. Generated by AI.
Investors talking about VAXX also mention these. Each card shows that asset’s own numbers for the past 24 hours.